JOSEPH WHALEN: Open Payments
NPI 1396501326 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 62 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $307 |
| MILLICENT US INC | 6 | $132 |
| Exact Sciences Corporation | 6 | $121 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Exeltis, USA Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Novo Nordisk Inc | 3 | $68 |
| ABBVIE INC. | 2 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
Products named: BREZTRI, Cologuard Collection Kit, FEMLYV, AIRSUPRA, GARDASIL 9, XIFAXAN, SLYND, REXULTI.
Industry payments across CT — which companies pay providers there.
